The Razor's Edge
2-Year Price History
Recent Price
(12/3/2008)
$16.50
52-Week Price
$11.97 - $27.81
Market Capitalization
$26.8 Billion
Most Recent Dividend
$0.25
About Schering-Plough Corp.
Schering-Plough Corporation is considered to operate in the Healthcare
sector. They specifically operate in the Drug Manufacturers/Major
business segment contained within the Drugs industry.
The Company discovers, develops and manufactures pharmaceuticals for three customer markets - human prescription, animal health, and consumer.
Ockham's Rating
Rating Specific Information Withheld
Premium Access Only
SGP Revenue
For a long time, value investors have used the current share price relative to sales per share levels as an important valuation tool. We utilize a historical weighted average methodology that treats recent years more importantly in the calculation. When looking at SGP through this framework, we can see that our weighted average historical high and low Price to Sales per share ratios over the last 10 years are 4.04x and 2.47x respectively.
Utilizing this range we can see that SGP’s current Price to Sales per share ratio of 1.40x is significantly below its average levels historically. In fact, with a current price of $16.81, SGP is a full 57% below its average Price to Sales ratio at comparable sales levels. This is a rare occurrence and, when taken in context of the other areas of our analysis, can be a strong positive for our outlook for SGP.
SGP Cash Earnings
Cash Earnings is always one of the most important factors to review for a company and, more importantly, an investment in a stock. SGP is significantly below its historical average multiple of cash earnings as calculated by Ockham. Similar to our analysis of sales per share, Ockham looks at the last 10 years of cash earnings levels for SGP to identify where the current high and low price levels have been historically in relation to profit per share. Again, we utilize a weighted average methodology which relies more heavily on recent years of data. This weighted average framework provides us with an average high Price to Cash Earnings ratio per share of 35.05 and a 22.75 low over the same period.
Now that SGP’s current price is $16.81 and its Price to Cash Earnings ratio is 5.17, we are very positive on its outlook from the cash earnings perspective. In fact, SGP is now trading a full 83% below its average historical Price to Cash Earnings ratio at these profit per share levels. When our clients ask us why SGP has great long term potential, the Cash Earnings levels to current stock is one of our primary reasons. But naturally, now we need for the overall market to recognize this disparity.
SGP Dividends
A strong dividend payment history is looked upon as a favorable characteristic on a company’s future and potentially can receive a positive Ockham rating. That being said, we don't require dividend payments for company's whose management has elected to forgo them entirely.
When reviewing dividend yields for SGP, we compare the historic high and low levels over the past, which is similar to our evaluation of Sales and Cash Earnings per share. Paying a dividend is not necessary for any company, but changes in dividend often can lend clues as to the health of the business. A rising dividend is a strong sign for an established company, as it reflects management's confidence in the company. SGP’s estimated annual dividend is $0.26 resulting in a current dividend yield of 1.55%. The highest dividend yield from SGP over recent history was 4.17% while the lowest dividend yield was 0.74%. It is never a good sign for a company to pay significantly lower dividends, in this case 36.86% below the median yield. Although, dividends are a relatively small portion of our analysis framework, we still see this as a negative factor.
Community Discussion